Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Acute disseminated encephalomyelitis


Other Names for this Disease

  • ADE
  • ADEM
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

How might acute disseminated encephalomyelitis (ADEM) be treated?

Treatment for acute disseminated encephalomyelitis (ADEM) is targeted at suppressing inflammation in the brain using anti-inflammatory drugs. Most individuals respond to intravenous corticosteroids such as methylprednisolone.  When corticosteroids fail to work, plasmapheresis or intravenous immunoglobulin therapy has been shown to produce improvement.  Additional treatment is symptomatic and supportive.[1]
Last updated: 7/27/2011

References
  1. NINDS Acute Disseminated Encephalomyelitis Information Page. National Institute of Neurological Disorders (NINDS). November 2010; http://www.ninds.nih.gov/disorders/acute_encephalomyelitis/acute_encephalomyelitis.htm. Accessed 7/27/2011.


Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Acute disseminated encephalomyelitis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
Other Names for this Disease
  • ADE
  • ADEM
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.